Pherecydes Pharma SA banner

Pherecydes Pharma SA
PAR:ALPHE

Watchlist Manager
Pherecydes Pharma SA Logo
Pherecydes Pharma SA
PAR:ALPHE
Watchlist
Price: 2 EUR Market Closed
Market Cap: €15.9m

Intrinsic Value

The intrinsic value for Pherecydes Pharma SA (ALPHE) under the Base Case is 2.41 EUR. Compared with the current market price of 2 EUR, the stock appears Undervalued by 17% .

Intrinsic value calculated using DCF
€2.41

Do our valuations actually work? See backtest results .

ALPHE Intrinsic Value
2.41
Undervaluation 17%
Intrinsic Value
Price €2
Monitor ALPHE
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €1.93
Get notified when the price drops into your buy zone
Intrinsic Value €2.41
Current Price €2
Margin of Safety 20% €1.93
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about ALPHE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ALPHE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pherecydes Pharma SA.

Explain Valuation
Alternatives to ALPHE

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Pherecydes Pharma SA

Efficiency

Earnings Waterfall
Pherecydes Pharma SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one ALPHE stock?

The intrinsic value for Pherecydes Pharma SA (ALPHE) under the Base Case is 2.41 EUR.

Is ALPHE stock undervalued or overvalued?

Compared with the current market price of 2 EUR, the stock appears Undervalued by 17% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett